QVT Financial’s Trillium Therapeutics Inc. TRIL Stock Holding History

QVT Financial’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-569,333	Closed	-$10M	–	68
2021 Q3	$10M	Buy	+569,333	New	+$6.65M	0.74%	25

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

QVT Financial's TRIL Position: Q4 2021 in Review

QVT Financial sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 569,333 shares — an estimated $10M sold.

QVT Financial first reported a position in TRIL in Q3 2021 and held it in 1 quarter. The position peaked at $10M in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

QVT Financial reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
QVT Financial sold 569,333 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $10M.
QVT Financial first reported a position in Trillium Therapeutics Inc. in Q3 2021 and held it in 1 quarter.
QVT Financial's Trillium Therapeutics Inc. position peaked at $10M in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on QVT Financial's 13F filing for Q4 2021, filed 14 Feb 2022.